Latest cancer news
- New drug combo for advanced breast cancer
- Common forms of increasing liver cancer
- People with multiple sclerosis have poor colon cancer survival
- Jeff Bridges bridges cancer in remission, but COVID ..
- Blood cancer patients benefiting from COVID boosters
- Want more news? Sign up for the MedicineNet Newsletter!
Thursday, September 18 (HealthDay News)-US Food and Drug Administration Approves First Skin Patch to Prevent Nausea and vomiting With people cancer Person receiving chemical treatment, Scottish manufacturer ProStrakan Group Plc said in a news release.
NS Sancuso (((Granisetron Transdermal SystemThe patch slowly releases the active drug into the bloodstream, relieving symptoms that may cause the following for up to 5 days. dehydration Malnutrition, the company said.
Clinical trials involving 641 patients with moderate or advanced levels nausea-Trigger chemical treatment I found that it works like an active ingredient, Granisetron, When taken in the form of tablets.Adverse effects of included patches constipation Mild skin reaction.
Copyright © 2008 ScoutNews, LLC. all rights reserved.
Anti-nausea patch approved for chemotherapy patients
Source link Anti-nausea patch approved for chemotherapy patients